[1]何秋波,尹光文,李红文,等.益赛普治疗泛发性脓疱型银屑病20例[J].郑州大学学报(医学版),2010,(04):668.
 [J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(04):668.
点击复制

益赛普治疗泛发性脓疱型银屑病20例()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2010年04期
页码:
668
栏目:
出版日期:
2010-07-30

文章信息/Info

作者:
何秋波尹光文李红文董慧婷
郑州大学第一附属医院皮肤科 郑州 450052
关键词:
脓胞型银屑病益赛普疗效
文献标志码:
A

参考文献/References:

[1]Moreland LW.Recent advances in antitumour necrosis factor (TNF) therapy in rheumatoid arthritis:focus on the soluble TNF receptor p75 fusion protein, etanercept[J].Biodrugs,1999,11(3):201
[2]Kamarashev J, Lor P, Forster A, et al.Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept[J]. Dermatology,2002,205(2):213
[3]郭静,王龙成,贾惠临.阿维A治疗银屑病的临床疗效观察[J].临床皮肤科杂志,2005,34(11):776
[4]姜兰香,巫毅,段正芳.阿维A胶囊治疗严重型银屑病[J].吉林大学学报:医学版,2004,30(5):735
[5]Bunikowski R,Gerhold K,Brautigam M,et al. Effect of lowdose cyclosporin a microemulsion on disease severity, interleukin6,interleukin8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis[J].Int Arch Allergy Immunol,2001,125(4):344
[6]Seishima M, Seishima M, Takemura M, et al. Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasis[J].Dermatology,1998,196(3):371
[7]Sagawa Y,Shiohara T,Imanishi K,et al.Is sustained production of tumor necrosis factoralpha relevant to the development of pustular psoriasis[J].Dermatology,1993,187(2):81
[8]王万卷,陈丽,王晓鹏,等.寻常型银屑病皮损中肿瘤坏死因子α、基质金属蛋白酶9及其抑制剂1的表达[J].西安交通大学学报:医学版,2007,28(3):322
[9]Breedveld FC.Tumour necrosis factor antagonists:infliximab, adalimumab and etanercept[J]. Ned Tijdschr Geneeskd,2005,149(41):2 273
[10]Malaviya R,Sun Y,Tan JK,et al. Etanercept induces apoptosis of dermaldendritic cells in psoriatic plaques of responding patients[J].J Am Acad Dematol,2006,55(4):590
[11]张永东,迟庆美.益赛普治疗银屑病的研究进展[J].中国皮肤性病学杂志,2008,22(5):311
[12]Tonelli LH,Postolache TT.Tumor necrosis factor alpha,interleukin1 beta,interleukin6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge [J]. Neurol Res,2005,27(7):679

更新日期/Last Update: